Influence of Delayed Initiation of Cyclosporine on Everolimus Pharmacokinetics in de Novo Renal Transplant Patients
Open Access
- 1 December 2003
- journal article
- clinical trial
- Published by Elsevier in American Journal of Transplantation
- Vol. 3 (12) , 1576-1580
- https://doi.org/10.1046/j.1600-6135.2003.00242.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Pharmacokinetics of an Everolimus-Cyclosporine Immunosuppressive Regimen Over the First 6 Months After Kidney TransplantationAmerican Journal of Transplantation, 2003
- Review of the proliferation inhibitor everolimusExpert Opinion on Investigational Drugs, 2002
- Exposure-response relationships for everolimus in de novo kidney transplantation: defining a therapeutic rangeTransplantation, 2002
- The General Public's Concerns about Clinical Risk in Live Kidney DonationAmerican Journal of Transplantation, 2002
- Differential Influence of Two Cyclosporine Formulations on Everolimus Pharmacokinetics: A Clinically Relevant Pharmacokinetic InteractionThe Journal of Clinical Pharmacology, 2002
- A PHASE I STUDY OF A 4-WEEK COURSE OF SDZ-RAD (RAD) IN QUIESCENT CYCLOSPORINE-PREDNISONE-TREATED RENAL TRANSPLANT RECIPIENTS1,2Transplantation, 1999
- SDZ RAD, A NEW RAPAMYCIN DERIVATIVETransplantation, 1997